1. Home
  2. EXEL vs VRNT Comparison

EXEL vs VRNT Comparison

Compare EXEL & VRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • VRNT
  • Stock Information
  • Founded
  • EXEL 1994
  • VRNT 1994
  • Country
  • EXEL United States
  • VRNT United States
  • Employees
  • EXEL N/A
  • VRNT 3800
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • VRNT EDP Services
  • Sector
  • EXEL Health Care
  • VRNT Technology
  • Exchange
  • EXEL Nasdaq
  • VRNT Nasdaq
  • Market Cap
  • EXEL 9.8B
  • VRNT 1.1B
  • IPO Year
  • EXEL 2000
  • VRNT N/A
  • Fundamental
  • Price
  • EXEL $36.50
  • VRNT $18.03
  • Analyst Decision
  • EXEL Buy
  • VRNT Buy
  • Analyst Count
  • EXEL 18
  • VRNT 6
  • Target Price
  • EXEL $37.59
  • VRNT $30.33
  • AVG Volume (30 Days)
  • EXEL 2.3M
  • VRNT 788.4K
  • Earning Date
  • EXEL 05-13-2025
  • VRNT 06-03-2025
  • Dividend Yield
  • EXEL N/A
  • VRNT N/A
  • EPS Growth
  • EXEL 170.77
  • VRNT 273.67
  • EPS
  • EXEL 1.76
  • VRNT 1.04
  • Revenue
  • EXEL $2,168,701,000.00
  • VRNT $909,186,000.00
  • Revenue This Year
  • EXEL $5.78
  • VRNT $7.52
  • Revenue Next Year
  • EXEL $10.94
  • VRNT $5.67
  • P/E Ratio
  • EXEL $20.74
  • VRNT $17.40
  • Revenue Growth
  • EXEL 18.50
  • VRNT N/A
  • 52 Week Low
  • EXEL $20.14
  • VRNT $14.15
  • 52 Week High
  • EXEL $40.26
  • VRNT $38.17
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 45.67
  • VRNT 52.02
  • Support Level
  • EXEL $35.34
  • VRNT $17.22
  • Resistance Level
  • EXEL $40.26
  • VRNT $18.12
  • Average True Range (ATR)
  • EXEL 1.21
  • VRNT 0.56
  • MACD
  • EXEL -0.09
  • VRNT 0.25
  • Stochastic Oscillator
  • EXEL 29.79
  • VRNT 84.12

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About VRNT Verint Systems Inc.

Verint Systems Inc with its subsidiaries, helps brands provide Boundless customer experience (CX) automation. AI offers a solution, and that's where Verint comes in. It empowers brands with groundbreaking AI via a next-gen open platform. Its Verint Open Platform helps organizations increase CX automation to achieve their strategic objectives and realize ROI. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: